119 related articles for article (PubMed ID: 16540009)
81. Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study.
Vandecasteele K; Delrue L; Lambert B; Makar A; Lambein K; Denys H; Tummers P; Van den Broecke R; Villeirs G; De Meerleer G
Int J Gynecol Cancer; 2012 May; 22(4):630-7. PubMed ID: 22237382
[TBL] [Abstract][Full Text] [Related]
82. Leptomeningeal metastasis of poorly differentiated uterine cervical adenosquamous carcinoma following reirradiation to metastatic vertebrae: A case report.
Lu YF; Fong VH; Wu WY; Wang LY; Hsieh CH
Medicine (Baltimore); 2017 May; 96(19):e6894. PubMed ID: 28489796
[TBL] [Abstract][Full Text] [Related]
83. A study of risk factors for ovarian metastases in stage Ib-IIIb cervical carcinoma and analysis of ovarian function after a transposition.
Yamamoto R; Okamoto K; Yukiharu T; Kaneuchi M; Negishi H; Sakuragi N; Fujimoto S
Gynecol Oncol; 2001 Aug; 82(2):312-6. PubMed ID: 11531285
[TBL] [Abstract][Full Text] [Related]
84. Value of PET-CT in avoiding multimodality therapy in operable cervical cancer.
Goyal BK; Singh H; Kapur K; Duggal BS; Jacob MJ
Int J Gynecol Cancer; 2010 Aug; 20(6):1041-5. PubMed ID: 20683414
[TBL] [Abstract][Full Text] [Related]
85. Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings.
Lin WC; Hung YC; Yeh LS; Kao CH; Yen RF; Shen YY
Gynecol Oncol; 2003 Apr; 89(1):73-6. PubMed ID: 12694656
[TBL] [Abstract][Full Text] [Related]
86. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264
[TBL] [Abstract][Full Text] [Related]
87. Ovarian metastasis in a transposed ovary 10 years after primary cervical cancer: the importance of histologic examination and review of literature.
Janse JA; Sie-Go DM; Schreuder HW
BMJ Case Rep; 2011 Jun; 2011():. PubMed ID: 22692488
[TBL] [Abstract][Full Text] [Related]
88. 18 F-FDG PET/CT Findings of Surgically Transposed Ovaries After Radical Hysterectomy in a Young Adult Patient.
Sakurada H; Nakamoto R; Takao Y; Moribata Y; Okuyama C
Clin Nucl Med; 2024 Jul; 49(7):e359-e361. PubMed ID: 38557760
[TBL] [Abstract][Full Text] [Related]
89. Metastasis from Cervical Cancer Presenting as a Pancreatic Head Mass - an Unexpected Diagnosis!
Datta D; Aggarwal D; Balakrishnan S; Varshney VK; Kumar R
J Gastrointest Cancer; 2023 Mar; 54(1):300-303. PubMed ID: 35226291
[TBL] [Abstract][Full Text] [Related]
90. A case of cardiac metastasis from uterine cervical carcinoma.
Okamoto K; Kusumoto T; Seki N; Nakamura K; Hiramatsu Y
Case Rep Obstet Gynecol; 2015; 2015():703424. PubMed ID: 25830052
[TBL] [Abstract][Full Text] [Related]
91. The role of computerized tomography of the pelvis in the presurgical staging of carcinoma of the cervix and of the ovary.
Facchini V; Michelassi PL; Gadducci A; Calderazzi A; Malventi M; Lanata F
Eur J Gynaecol Oncol; 1984; 5(3):214-20. PubMed ID: 6734662
[TBL] [Abstract][Full Text] [Related]
92. 18F-FDG uptake on PET/CT in transposed ovaries.
Zissin R; Even-Sapir E
AJR Am J Roentgenol; 2006 Jan; 186(1):267-8; author reply 268. PubMed ID: 16357418
[No Abstract] [Full Text] [Related]
93. Androgen-secreting tumour in a transposed ovary.
Sanusi TD; Decruze B; George S
BMJ Case Rep; 2009; 2009():. PubMed ID: 21754970
[TBL] [Abstract][Full Text] [Related]
94. Rare Presentation of Isolated Scar Site Recurrence in a Case of Carcinoma Cervix.
Parida GK; Mitra S; Jena S; Suman A; Muthu GS
Indian J Nucl Med; 2020; 35(1):68-69. PubMed ID: 31949375
[TBL] [Abstract][Full Text] [Related]
95. [Ovarian and para-aortic recurrence from cervix cancer detected by PET/CT].
Ubieto MA; Paredes P; Martínez S; Ortín J; Fuster D; Torné A; Setoain FJ; Pahisa J; Pons F; Lomeña F
Rev Esp Med Nucl; 2006; 25(1):31-4. PubMed ID: 16540009
[TBL] [Abstract][Full Text] [Related]
96. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
[TBL] [Abstract][Full Text] [Related]
97. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
[TBL] [Abstract][Full Text] [Related]
98. Sarcoidosis mimicking metastatic gynaecological malignancies: a diagnostic and therapeutic challenge?
Mapelli P; Mangili G; Picchio M; Rabaiotti E; Gianolli L; Messa C; Candiani M
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):314-7. PubMed ID: 23270913
[TBL] [Abstract][Full Text] [Related]
99. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
Chung YL; Horng CF; Lee PI; Chen FL
BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959
[TBL] [Abstract][Full Text] [Related]
100. FIGO IVB (para-aortic lymph adenopathy) squamous cell carcinoma of uterine cervix associated with a left pelvic kidney: a therapeutic challenge.
Ali N; Karsan F; Abbasi AN; Khan ZR
J Pak Med Assoc; 2012 Jun; 62(6):615-6. PubMed ID: 22755354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
